Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression?

Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression?

Bibliographic Details
Main Authors: Rosa Maria Corbo, Rita Businaro, Daniela Scarabino
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Neural Regeneration Research
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=7;spage=1397;epage=1398;aulast=Corbo

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=7;spage=1397;epage=1398;aulast=Corbo

Similar Items